Open original FDA record ↗Recall record
- FDA identifier
- Z-1726-2011
- Company in FDA record
- Bio-Rad Laboratories, Inc.
- FDA classification date
- Mar 18, 2011
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Firm's Correction involves advising customers who have implemented a Laboratory Information System (LIS) that they need to ensure quantitative results have passed all validation criteria prior to reporting patient results. When a patient result fails a Validation Rule, the qualitative result will indicate "INVALID".
Source facts
- Action
- The firm, Bio-Rad, sent an "URGENT MEDICAL DEVICE CORRECTION" letter dated January 20, 2011 to all customers. The letter described the product, problem and actions to be taken. The customers were instructed to review the PhD Worklist Results to verify that all validations have passed and that the quantitative results are valid; to translate (if necessary) the customer letter, add local contacts information, distribute to all active PhD System customers in their region and provide tracking documentation to CSD-RA for all customers who received the customer letter. If you have any questions, contact the Bio-Rad CSD Regulatory Affairs Department at (510) 741-4618.
- Initiated
- 2011-01-20
- Root cause
- Other
- Terminated
- 2011-08-17
- Distribution
- Worldwide distribution: USA and countries including:Canada, China, Australia, New Zealand, Czech Republic, France, Hong Kong, India, Italy, Korea, Singapore, Sweden, Taiwan and United Kingdom.
- Recall number
- Z-1726-2011
- Recall status
- Terminated
- CDRH record ID
- 97382
- FDA classified
- 2011-03-18
- Recall event number
- 57778